CA2539041A1 — Dry powder composition comprising a benzodiazepine for pulmonary inhalation
Assigned to Vectura Ltd · Expires 2005-03-24 · 21y expired
What this patent protects
The present invention relates to dry powder pharmaceutical compositions comprising a benzodiazepine for administration by inhalation, and in particular, benzodiazepine dry powder compositions and inhaler devices for dispensing the same.
USPTO Abstract
The present invention relates to dry powder pharmaceutical compositions comprising a benzodiazepine for administration by inhalation, and in particular, benzodiazepine dry powder compositions and inhaler devices for dispensing the same.
Drugs covered by this patent
- glycopyrrolate (Glycopyrrolate) · Yonsei University
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.